31 – 40 of 40
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- « previous
- 1
- 2
- 3
- 4
- next »
- 2017
-
Mark
Lung transplantation and survival outcomes in patients with oxygen-dependent COPD with regard to their alpha-1 antitrypsin deficiency status
(
- Contribution to journal › Article
-
Mark
Measures of bronchodilator response of FEV1, FVC and SVC in a Swedish general population sample aged 50–64 years, the SCAPIS pilot study
(
- Contribution to journal › Article
-
Mark
Health status and lung function in the Swedish alpha 1-antitrypsin deficient cohort, identified by neonatal screening, at the age of 37-40 years
(
- Contribution to journal › Article
-
Mark
The effect of COPD severity and study duration on exacerbation outcome in randomized controlled trials
(
- Contribution to journal › Article
- 2016
-
Mark
Persistent disabling breathlessness in chronic obstructive pulmonary disease
(
- Contribution to journal › Article
-
Mark
Author’s reply
(
- Contribution to journal › Letter
-
Mark
Bronchodilator response of advanced lung function parameters depending on COPD severity
(
- Contribution to journal › Article
-
Mark
Vital capacity and COPD : The Swedish CArdioPulmonary bioImage Study (SCAPIS)
(
- Contribution to journal › Article
-
Mark
Cause-specific mortality in individuals with severe alpha 1-antitrypsin deficiency in comparison with the general population in Sweden
(
- Contribution to journal › Article
-
Mark
Prescription of opioids for breathlessness in end-stage COPD : A national population-based study
(
- Contribution to journal › Article
- « previous
- 1
- 2
- 3
- 4
- next »